Correlation Between Corvus Pharmaceuticals and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Fate Therapeutics, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Fate Therapeutics.
Diversification Opportunities for Corvus Pharmaceuticals and Fate Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Corvus and Fate is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and Fate Therapeutics
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 0.91 times more return on investment than Fate Therapeutics. However, Corvus Pharmaceuticals is 1.1 times less risky than Fate Therapeutics. It trades about -0.09 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 756.00 in Corvus Pharmaceuticals on September 23, 2024 and sell it today you would lose (257.00) from holding Corvus Pharmaceuticals or give up 33.99% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Corvus Pharmaceuticals vs. Fate Therapeutics
Performance |
Timeline |
Corvus Pharmaceuticals |
Fate Therapeutics |
Corvus Pharmaceuticals and Fate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Corvus Pharmaceuticals and Fate Therapeutics
The main advantage of trading using opposite Corvus Pharmaceuticals and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.Corvus Pharmaceuticals vs. Fate Therapeutics | Corvus Pharmaceuticals vs. Sana Biotechnology | Corvus Pharmaceuticals vs. Caribou Biosciences | Corvus Pharmaceuticals vs. Arcus Biosciences |
Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |